CYP2E1 and metabolic dysfunction-associated steatohepatitis: Furthermore, it was shown that over-expression of hepatic CYP2E1 in vitro and in vivo promoted the development of hepatic IR44, 45, leading to NASH and fibrosis, as similar to those in age-dependent fibrosis46.